Skip to main content
Fig. 3 | Virology Journal

Fig. 3

From: Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections

Fig. 3

Protective effects of maternal antibodies from immunized mice on neonatal mice against EV71 infection. a A schematic representation of passive immunization and viral infection protocol. The protective effect of the fusion protein vaccine post 200 LD50 (b) or 10 LD50 (c) of viral infection were evaluated in 1-day-old neonatal mice (n = 12 ~ 15) born from immunized dams. Survival rates were analyzed via Kaplan–Meier analysis

Back to article page